Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,175 trials

NCT07022587
Recruiting
Bioresorbable Sirolimus-eluting scaﬀold in de Novo Coronary Artery Lesions
Not applicable · China · 1 site
Registry update: 13 Feb 2026
NCT07287982
Recruiting
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
Phase 2 · Australia, Canada, United Kingdom, United States · 28 sites
Registry update: 8 Oct 2026
NCT07479927
Recruiting
Telematic Cognitive Training and Mindfulness in Pediatric Patients After CAR-T Cell Therapy, Single Hematopoietic Allogeneic Transplant or Chemotherapy
Not applicable · Spain · 1 site
Registry update: 18 Mar 2026
2024-518167-35-01
Recruiting
Phase II, multicentre, randomised, open-label trial with MAP +/- denosumab regimen for the treatment of patients with metastatic osteosarcoma
Phase 2 · Italy · 17 sites
Registry update: 7 Aug 2025
NCT07284420
Recruiting
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
Phase 2 · Belgium, Germany, Spain, Greece, Italy, Japan, Netherlands, Poland, United States · 39 sites
Registry update: 24 Sept 2026
NCT07231484
Recruiting
Effects of Grape Consumption on the Immune-Gut Axis in Obesity
Not applicable · United States · 1 site
Registry update: 31 Jul 2026
NCT07252440
Recruiting
A Study to Evaluate the Efficacy and Safety of TTYP01 Tablets in Early Symptomatic Alzheimer's Disease
Phase 2 · China · 1 site
Registry update: 16 Jul 2026
NCT07167693
Recruiting
Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes
Phase 1/2 · United States · 1 site
Registry update: 12 Feb 2026
NCT07300241
Recruiting
Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
Phase 1 · United States · 16 sites
Registry update: 4 Nov 2026
NCT07225946
Recruiting
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Phase 3 · Australia, Belgium, Brazil, Canada, China, Germany, Spain, France, United Kingdom, Italy, Japan, South Korea, Malaysia, Puerto Rico, Taiwan, United States · 165 sites
Registry update: 3 Nov 2026
NCT06861088
Recruiting
The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer
Phase 3 · United States · 3 sites
Registry update: 2 Feb 2026
NCT07187778
Recruiting
Phase II Trial of Single Agent Belzutifan or Pembrolizumab Versus Combination as Neoadjuvant Therapy in Clear Cell Renal Cell Carcinoma (BLAZE)
Phase 2 · United States · 2 sites
Registry update: 9 Nov 2026
NCT07101432
Recruiting
Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK)
Phase 1 · United States · 1 site
Registry update: 5 Oct 2026
NCT07294170
Recruiting
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
Not applicable · Belgium, Germany, Spain, Greece, Italy, Japan, Poland, United States · 35 sites
Registry update: 26 Oct 2026
2025-522371-29-00
Recruiting
A trial to learn how safe AZD4512 is with and without other cancer drugs and how it works in the bodies of people with B-cell non-Hodgkin lymphoma (B-NHL)
Phase 1/2 · Italy · 3 sites
Registry update: 3 Aug 2026
2024-512503-39-00
Recruiting
Registry and clinical trial comparing standard intensity and reduced intensity treatment in patients with AML or CLL who do not have residual disease.
Phase 4 · Germany, France, Italy, Poland · 53 sites
Registry update: 1 Oct 2026
NCT07032714
Recruiting
Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma
Phase 1 · United States · 3 sites
Registry update: 13 Apr 2026
NCT07252739
Recruiting
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
Phase 2 · Chile, China, Spain, Finland, Greece, Hong Kong, Italy, South Korea, Netherlands, Poland, Thailand, Ukraine, United States · 45 sites
Registry update: 2 Sept 2026
NCT07190690
Recruiting
Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions
Not applicable · Spain · 20 sites
Registry update: 10 Aug 2026
NCT07596693
Recruiting
KXV01 Injection in Patients With Advanced Solid Tumor (Including Osteosarcoma and Sarcoma)
Phase 1 · China · 1 site
Registry update: 19 May 2026

Ordered by registry start date. Freshness and sponsorship never change the order.